ApconiX is delighted to welcome Dr Laurence Bishop to the team as our Head of Business Development. Laurence is an experienced DMPK and toxicological scientist with 20 years’ experience of nonclinical drug development. Specialising in business development for the past 13 years, we are looking forward to Laurence playing a key role in our growth [...]
ApconiX is pleased to announce that Dr Guy Healing has been appointed to an Honorary Professorship in the School of Pharmacy at the University of East Anglia (UEA), Norwich, UK. Guy first became involved with the UEA when he worked for AstraZeneca. One of the University’s PhD projects was co-sponsored by AstraZeneca and Guy was [...]
As we all continue to live through these very difficult times, our main priority is the safety and wellbeing of our staff, their families and the community. As an essential facility in the development of new medicines, we remain fully operational. We are following government guidelines and are keeping all our clients updated as the [...]
ApconiX welcomes Olivia Turner to the team. Olivia has just finished her second year studying Biomedical Sciences at The University of Sheffield and will be working at ApconiX as an industry placement student until Christmas. She will then join Aptus Clinical and continue her placement until the end of June. Choosing to take the Physiology [...]
Dr Richard Knight and Professor Ruth Roberts are travelling to Boston at the end of August to meet with old colleagues and new contacts, promoting the company’s services in Project Toxicology, Ion Channel Screening and Assay Development, Target Safety Assessments and all aspects of Nonclinical Programme Design. They will be joined by Dr Andrew Winkley. [...]
ApconiX is delighted to welcome William O'Brien as their new Finance Director. William has a strong background in high-tech development management and corporate finance. William is the founder of WOCO, a specialist R&D tax and financial advisory business based at Alderley Park, Cheshire. A seasoned leader, he previously worked across a wide range of industries [...]
ApconiX is delighted to welcome Ian Slater to the team. Ian has spent many years in the pharmaceutical industry as a toxicology Study Director and Study Monitor and he joins our nonclinical study monitoring team. Ian was previously an Associate Principal Toxicologist in the Regulatory Safety group at AstraZeneca and has a wealth of experience [...]
Today is the last day of Society of Toxicology 58th Annual Meeting & Expo 2019. It's been a fabulous few days in Baltimore with the ApconiX team meeting up with old friends and new. Brilliant talks by Dr Jane Barber, Dr Paul Duffy and Dr Michael Morton. "All the presentations were excellent. Lots of great [...]
Dr Michael Morton, Professor Ruth Roberts and Dr Richard Knight flew to Sweden to celebrate the opening of ApconiX AB in Gothenburg by sharing coffee and cake (fika) with our fellow tenants in the BioVentureHub. Experienced toxicologists Drs Steffen Ernst and Björn Dahl, who are based at the new Swedish office, joined the three Directors [...]
At the Society of Toxicology 58th Annual Meeting and ToxExpo from March 10th to 14th at the Baltimore Convention Center, Dr Paul Duffy of ApconiX will be giving a talk as part of the Safety Assessment: Pharmaceutical—Drug Development I Platform on Wednesday March 13th 9:15am – 9:30am in Convention Center Room 321. New Opportunities for a Psychoactive Psilocybin in [...]
